The chemical substance known as "3-[3-({[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride" with CAS number 1086026-38-1 is a complex organic compound characterized by its intricate bicyclic structure and multiple functional groups. It features a benzazepine core, which is a fused bicyclic system containing a benzene ring and a seven-membered nitrogen-containing ring. The presence of methoxy groups indicates potential for increased lipophilicity and biological activity. The hydrochloride salt form suggests enhanced solubility in aqueous environments, which is often beneficial for pharmacological applications. The compound's structure includes a chiral center, denoted by the (7S) configuration, which may influence its biological interactions and pharmacodynamics. Overall, this compound is likely to be of interest in medicinal chemistry, particularly in the development of therapeutic agents, due to its unique structural features and potential biological activity.

3-[3-({[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride

1086026-38-1: The chemical substance known as "3-[3-({[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride" with CAS number 1086026-38-1 is a complex organic compound characterized by its intricate bicyclic structure and multiple functional groups. It features a benzazepine core, which is a fused bicyclic system containing a benzene ring and a seven-membered nitrogen-containing ring. The presence of methoxy groups indicates potential for increased lipophilicity and biological activity. The hydrochloride salt form suggests enhanced solubility in aqueous environments, which is often beneficial for pharmacological applications. The compound's structure includes a chiral center, denoted by the (7S) configuration, which may influence its biological interactions and pharmacodynamics. Overall, this compound is likely to be of interest in medicinal chemistry, particularly in the development of therapeutic agents, due to its unique structural features and potential biological activity.

CAS 1086026-38-1

3-[3-({[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride

Dehydro Ivabradine

Ref: ST-EA-CP-I11004